- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3390/cells8101279
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2019
- Creator
- DOI
-
10.18154/RWTH-2022-11484
- URN
-
urn:nbn:de:101:1-2023012100382302624982
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Levada, Kateryna
- Omelyanchik, Alexander
- Rodionova, Valeria
- Weiskirchen, Ralf
- Bartneck, Matthias
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2019
Other Objects (12)
Magnetic-assisted treatment of liver fibrosis
Cell therapy in liver fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Magnetic-assisted treatment of liver fibrosis
Cell therapy in liver fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Magnetic-assisted treatment of liver fibrosis
Cell therapy in liver fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis